Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lock

Showing results (161-170 of 220) with videos related to

Pageof 22
Sort By:
Blood|June 26, 2016
Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemiaSeong Lin Khaw, Santi Suryani, Kathryn Evans, et al.
Cell Stem Cell|July 3, 2009
Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cellsLiqing Jin, Erwin M Lee, Hayley S Ramshaw, et al.
British Journal of Cancer|April 10, 2021
Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofinMawar Karsa, Angelika Kosciolek, Angelika Bongers, et al.
Cell Stem Cell|December 7, 2014
Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapyClaudia Bruedigam, Frederik O Bagger, Florian H Heidel, et al.
Blood|June 28, 2015
AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemiaDonya Moradi Manesh, Jad El-Hoss, Kathryn Evans, et al.
Leukemia|April 9, 2016
MAPK/ERK2 phosphorylates ERG at serine 283 in leukemic cells and promotes stem cell signatures and cell proliferationY Huang, J A I Thoms, M L Tursky, et al.
Blood Cancer Journal|February 27, 2025
Targeting osteoclasts for treatment of high-risk B-cell acute lymphoblastic leukemiaRishi S Kotecha, Sarah M Trinder, Anastasia M Hughes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Molecular characterization of the pediatric preclinical testing panelGeoffrey Neale, Xiaoping Su, Christopher L Morton, et al.
Cancer Research|August 7, 2016
Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse AnalysisBrendan Murphy, Han Yin, John M Maris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2019
A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921)Yael P Mossé, Elizabeth Fox, David T Teachey, et al.
Pageof 22

Showing results (161-170 of 220) with videos related to

Sort By:
Pageof 22
Blood|June 26, 2016
Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemiaSeong Lin Khaw, Santi Suryani, Kathryn Evans, et al.
Cell Stem Cell|July 3, 2009
Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cellsLiqing Jin, Erwin M Lee, Hayley S Ramshaw, et al.
British Journal of Cancer|April 10, 2021
Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofinMawar Karsa, Angelika Kosciolek, Angelika Bongers, et al.
Cell Stem Cell|December 7, 2014
Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapyClaudia Bruedigam, Frederik O Bagger, Florian H Heidel, et al.
Blood|June 28, 2015
AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemiaDonya Moradi Manesh, Jad El-Hoss, Kathryn Evans, et al.
Leukemia|April 9, 2016
MAPK/ERK2 phosphorylates ERG at serine 283 in leukemic cells and promotes stem cell signatures and cell proliferationY Huang, J A I Thoms, M L Tursky, et al.
Blood Cancer Journal|February 27, 2025
Targeting osteoclasts for treatment of high-risk B-cell acute lymphoblastic leukemiaRishi S Kotecha, Sarah M Trinder, Anastasia M Hughes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Molecular characterization of the pediatric preclinical testing panelGeoffrey Neale, Xiaoping Su, Christopher L Morton, et al.
Cancer Research|August 7, 2016
Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse AnalysisBrendan Murphy, Han Yin, John M Maris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2019
A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921)Yael P Mossé, Elizabeth Fox, David T Teachey, et al.
Pageof 22